HSK47977

· Haisco Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HSK47977, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

See pricing